NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

FeMike,

Folks are looking past your properly conservative approach because it’s too toned down for the reality which is that manufacturing, needed regulatory changes, revised SAP buy in and patent protection has been holding NWBO hostage since 2015 when regulators kept 17 SOC/placebo patients out of this trial because of ethical concerns by identifying SOC/placebo only before crossover as unethical when the patients had an outside chance to get the treatment on a compassionate use basis. Fraunhofer claimed enrollment was only done to the point statistically necessary and enrollment from Germany was never disclosed so as to protect the blind and the public from having reason to form a lynch mob to speed up “the process”. So yes you are “technically” correct but the exuberant are also correct in assuming “ the process” is nothing more than a very burdensome necessity created to protect the status quo which your “technically correct” comments represent. You are meeting a rather significant disdain on this board for defending the process thinking of the status quo is all. Since 2015 the cost to investors has been time opportunity loss but buying in the teens kind of made up for that big time for some of us. Today is a day to celebrate without pulling back so hard on the reigns. Best wishes.